Skip to main content
. 2013 Apr 15;5(1):e2013030. doi: 10.4084/MJHID.2013.030

Figure 3.

Figure 3

BM after azacitidine therapy reveals myelodysplastic features: dismegakariocytopoiesis and disgranulocytopoiesis are evident; rare erytroid islands with dyserythropoietic morphology are also detected (a). Cells with immature-blastic morphology are rare (less than 5%). Insert b: Gomori stain shows a diffuse and strong (grade-2) BM fibrosis.